Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    IL-6R alpha Antibody (255821), DyLight 488, Novus Biologicals™
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rat Monoclonal Antibody
Supplier: Novus Biologicals FAB1830K
                        
                            
                        
                        
                        
                            
                        
                        
                        
                        
                            
                                    
                                This item is not returnable.
                                View return policy
                                
                        
                    
                Description
IL-6R alpha Monoclonal antibody specifically detects IL-6R alpha in Mouse samples. It is validated for Flow CytometrySpecifications
| IL-6R alpha | |
| Monoclonal | |
| DyLight 488 | |
| CD126, gp80, IL6Q, IL6R, IL-6R-1, IL6RA, IL-6RA, IL6RQ, interleukin 6 receptor | |
| Mouse myeloma cell line NS0-derived recombinant mouse IL-6 R alpha , Leu20-Glu357, Accession # P22272 | |
| 0.5 mL | |
| Primary | |
| Mouse | |
| Purified | 
| Flow Cytometry | |
| 255821 | |
| 50mM Sodium Borate | |
| Rat | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 3570 | |
| Store at 4°C in the dark. | |
| IgG2a | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            